Waldencast completes sale of Obagi Medical to Bridgepoint valued up to $460 million
Reuters2026/07/30 21:05- Waldencast completed the sale of Obagi Medical to Bridgepoint in a deal valued at up to USD 460 million, subject to customary closing adjustments.
- Proceeds were used to repay all outstanding senior term loan facility borrowings, strengthening the balance sheet.
- The group will focus on accelerating global growth at Milk Makeup, its remaining brand.
- Founders Michel Brousset and Hind Sebti, alongside CFO Manuel Manfredi, will move to lead Obagi Medical with Bridgepoint.
- Executive Chairman Felipe Dutra will serve as principal executive officer and principal financial officer.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
OPEC+ agrees to keep oil output policy unchanged for October
US military strikes Iranian oil tanker, triggering geopolitical risks as Brent crude nears $97 mark
Following the US military's attack on Iranian oil tankers and Iran's announcement of new restricted navigation zones outside the Strait of Hormuz, market concerns over prolonged disruptions in key energy transport routes have intensified, leading to a sharp rise in international oil prices.
Geopolitical tensions overshadowing production cuts: OPEC+ maintains quotas unchanged, paper adjustments fail to resolve physical supply dilemmas
OPEC+ major oil producers, led by Saudi Arabia and Russia, held a monthly video conference last Sunday and decided to keep the crude oil production quota for October unchanged, continuing the previous tone of stable production following a series of symbolic production increases.
IX Biopharma seeks SGX-ST trading halt lift for shares in Singapore
Crypto prices
More
